Micronutrients & recovery
For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.
If you are a postmenopausal woman at high risk, these four drugs are the gold standard first-line treatments. They significantly reduce the chance of breaking a bone (by 30-70%). Discuss the specific dosing schedule (pill vs. injection) with your doctor, ensuring you also take 1200mg of calcium and 800-1000 IU of Vitamin D daily.
For menopausal women requiring treatment of osteoporosis, alendronate, risedronate, zoledronic acid and denosumab can be used as first-line therapies for prevention of hip, nonvertebral and vertebral fractures [grade A].
Why this rating
Grade A recommendation based on systematic reviews and meta-analyses of randomized trials.
Source
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
A. Papaioannou et al. · Canadian Medical Association Journal · 2010
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →